Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Petmed Express ( (PETS) ) has shared an announcement.
On August 11, 2025, PetMed Express, Inc. announced significant management changes with the resignation of CEO Sandra Campos and CFO Robyn D’Elia, both of whom entered into separation agreements to provide consulting services for three months. Leslie C.G. Campbell has been appointed as Interim CEO, and Doug Krulik as Interim CFO, as the company initiates a search for permanent replacements. These changes come amid an ongoing investigation by the Audit Committee into revenue recognition and other operational issues, potentially impacting company performance and stakeholder confidence.
The most recent analyst rating on (PETS) stock is a Sell with a $3.50 price target. To see the full list of analyst forecasts on Petmed Express stock, see the PETS Stock Forecast page.
Spark’s Take on PETS Stock
According to Spark, TipRanks’ AI Analyst, PETS is a Neutral.
Petmed Express shows a mixed financial performance with strong balance sheet stability but weak profitability and inconsistent cash flow. Technical analysis indicates a bearish trend with oversold conditions, while valuation metrics suggest the stock may be overvalued. The earnings call highlights progress in profitability and strategic investments, but challenges remain in sales and competitive pressures. Overall, the stock score reflects these combined factors, indicating moderate potential with significant risks.
To see Spark’s full report on PETS stock, click here.
More about Petmed Express
Founded in 1996, PetMeds is a pioneer in the direct-to-consumer pet healthcare sector. As a trusted national online pharmacy, PetMeds is licensed across all 50 states and staffed with expert pharmacists dedicated to supporting pet wellness and the veterinarians who serve them. Through its PETS family of brands, the Company offers a comprehensive range of pet health solutions – including top-brand and generic pharmaceuticals, compounded medications, and better-for-your-pet OTC supplements and nutrition.
Average Trading Volume: 142,753
Technical Sentiment Signal: Sell
Current Market Cap: $62.59M
Find detailed analytics on PETS stock on TipRanks’ Stock Analysis page.